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Received November 9, 2010; accepted August 9, 2011AbstractMycotic subclavian artery pseudoaneurysms are rare. There are controversies over the surgical or endovascular approach as the treatment of
choice for these lesions. The standard surgical debridement might not be a choice for poorly surgically reachable lesions or for patients with
multiple comorbidities. Endovascular aneurysm repair may be an effective alternative in selected cases. This treatment was rarely reported
previously. Herein, we present a high-surgical-risk case with a highly suspected left subclavian arterial mycotic pseudoaneurysm, which,
although difficult to approach surgically, was successfully managed with stent grafting and a complete antibiotic treatment course. An 89-year-
old male was admitted due to intermittent fever and hemoptysis for 2 months. Salmonella group B was cultured from his sputum, and a 3.5 cm
pseudoaneurysm was identified by chest multidetector-row computed tomography (MDCT) angiogram. Endovascular treatment with a graft stent
was chosen due to high surgical risk and difficult surgical access to the lesion. The intervention was well planned ad hoc, based on MDCT
images and meticulously performed by dual endovascular approaches. Antibiotics were continued after the procedure, and the patient was
discharged from the hospital. As MDCT disclosed near-complete regression of the pseudoaneurysms 2 months later and the patient was in
healthy status, antibiotics were continued for 6 months. He was readmitted 11 months later due to lacunar infarction with minor pneumonia over
the left lower lung in which Salmonella enteritis was also diagnosed. After this acute event, he was again hospitalized 14 days later due to sepsis
with adult respiratory distress syndrome and shortly expired despite all emergent treatment measures. No evidence of local subclavian infection
recurrence was noted throughout or related to subsequent events. In conclusion, endovascular treatment of an infected subclavian artery
pseudoaneurysm could be a choice in selected patients, but treatment of underlying infection determines the clinical outcome.
Copyright  2012 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved.
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Aneurysms of the subclavian arteries are rare and usually
atherosclerotic or post-stenotic.1 However, pseudoaneurysms
of the subclavian artery are mostly traumatically induced, with
most cases following central-line catheter placement, which
may also injure unilateral vertebral arteries.2 These* Corresponding author. Dr. Wen-Lieng Lee, Cardiovascular Center, Tai-
chung Veterans General Hospital, 160, Section 3, Chung-Kang Road, Tai-
chung 407, Taiwan, ROC.
E-mail address: wllee@vghtc.gov.tw (W.-L. Lee).
1726-4901/$ - see front matter Copyright  2012 Elsevier Taiwan LLC and the C
http://dx.doi.org/10.1016/j.jcma.2012.06.019pseudoaneurysms of the subclavian artery could be treated by
ultrasound-guided local thrombin injection,2,3 coil emboliza-
tion,4 or endovascular treatment.5 On the other hand, mycotic
subclavian artery pseudoaneurysms are rare,6e9 occurring
mostly as a complication of drug addiction. They can present
with pulsatile mass, chest pain, distal thromboembolism, or
signs of local tissue compression,10e12 but they can also be
lethal due to local perforation. Standard surgical treatment
consists of surgical debridement with extra-anatomic bypass
or in situ graft placement, followed by long-term antibiotic
treatment.13 However, it might not be a choice for poorly
surgically reachable lesions or for patients who arehinese Medical Association. All rights reserved.
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other hand, endovascular aneurysm repair may be a less
invasive, but effective, alternative to open repair of mycotic
aneurysms, especially in high-risk patients and for surgically
inaccessible lesions. In certain cases, it could be the only
choice. This treatment was rarely reported earlier.8
2. Case report
An 89-year-old man was admitted due to intermittent fever
and hemoptysis for a total of 2 months. He was first diagnosed
to have pneumonia and treated at a local hospital. However,
fever and hemoptysis relapsed 1 week prior to current
admission. He had hypertension and was under medical
control for about 10 years. No chest trauma or surgical history
could be elicited. During the current hospital stay, Salmonella
group B was cultured from his sputum and antibiotic treatmentFig. 1. (A) The CXR showed a mass lesion in the left upper lung field involving the
medium MDCT in saggital section showed a 3.2  2.7 cm2, previously ruptured m
surrounding blood clot and reacting tissues (7.2  6.8 cm2 in size). (D) The
MDCT ¼ multidetector-row computed tomography.with cefotaxime was initiated. Chest roentgenogram showed
a mass lesion in the left retroclavicular region, extending to the
aortic knob (Fig. 1A). Chest multidetector-row computed
tomography (MDCT) angiogram showed a contained ruptured
pseudoaneurysm, 35 mm in diameter with a neck of 13 mm, at
the proximal left subclavian artery and proximal to the
vertebral artery origin (Fig. 1BeD). Therefore, left subclavian
arterial mycotic aneurysm was highly suspected 3 days after
antibiotic treatment. Complete aneurysm extrusion was ach-
ieved by endovascular approach with a graft stent, but no open
repair was intended due to high surgical risk and poor lesion
access to the retroclavicular area. The occlusion procedure
was planned ad hoc in detail, based on MDCT images, and
meticulously performed by bilateral arterial access with an
11F introducer sheath placed via left brachial cutdown and an
8F sheath in the right femoral artery. A 10  50 mm self-
expandable stent graft (Wallstent, Boston Scientific, Galway,retroclavicular region and extending to the aortic knob. (B and C) The contrast
ycotic aneurysm (arrows) at the proximal left subclavian artery contained by
volume-rendered reconstructive image is shown here. CXR ¼ chest X-ray;
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sheath and positioned precisely under contrast guidance with
an 8F JR4 guide through the femoral sheath to avoid jailing in
the left vertebral artery and, at the same time, to prevent stent
dislodgement into the aorta. Complete sealing-off of the
aneurysm was achieved by postdilatation with a 10  20 mm
balloon up to 10 bar along the entire device for multiple times.
Minimal contrast leakage into the pseudoaneurysm was still
present on final control angiogram, but the flow was very
sluggish. There was no procedural complication or neurolog-
ical sequela. After the procedure, hemoptysis and fever
subsided until 2 weeks later, when the patient again suffered
from hemoptysis that was more massive than before, severe
dyspnea, and desaturation of blood oxygen. Emergency intu-
bation was done and MDCT was repeated, but it revealed no
endoleak (Fig. 2A). Bronchoscopy was also performed, and no
active bleeding point could be identified. The bleeding was
presumed to be due to bronchial artery erosion by smoldering
infection in the extruded mycotic aneurysm. After conserva-
tive treatment for 1 week, the patient was weaned from the
ventilator successfully. Owing to suspected antibiotic-related
neutropenia 4 weeks later, cefotaxime was substituted by
ciprofloxacin. Finally, the patient was discharged from
hospital 55 days after his admission. Ciprofloxacin was
continued for another 5 months and then stopped as the
patient’s general condition was quite stable, and MDCT
follow-up 2 months post intervention revealed dramatic
reduction in the aneurysm size. The patient was readmitted 11
months post intervention and was hospitalized for 11 days due
to lacunar infarction with minor pneumonia over the left lower
lung, but the left upper lung adjacent to the previous mycotic
aneurysm was completely clear. During the hospitalization,
Salmonella enteritis was diagnosed based on abdominal
distension, dull pain, gastrointestinal tract bleed, and positive
stool culture growth. However, an abdominal CT scan showed
negative finding. After antibiotic treatment, he was discharged.
However, he was admitted again 14 days later due to sepsisFig. 2. The transverse-view contrast medium MDCT image taken 14 days after endo
and no endoleak. (A) The blood clot was still noted around the treated mycotic a
vascular treatment in the right clearly showed almost complete resolution of both
obscured due to partial volume effect. MDCT ¼ multidetector-row computed tomwith adult respiratory distress syndrome, hypotension, brady-
cardia, and hypothermia. The patient soon died despite all
emergent treatment measures. No evidence of local subclavian
infection recurrence was noted throughout or related to
subsequent events.
3. Discussion
Pseudoaneurysms of the subclavian artery are mostly
traumatic, with most cases following central-line cannula-
tions.2 These catheterization-injury-related pseudoaneurysms
are usually located at or distal to the subclavianevertebral
junctions,2 and endovascular strategy is the treatment of
choice in modern practice.5 They can also occur as a conse-
quence of shoulder dislocation,14 local balloon dilatation,15
BlalockeTaussing shunting,16 or type IV EhlerseDanlos
syndrome.17 It may also follow infection of previously placed
stents.18 Our reported case did not have such histories. Instead,
the pseudoaneurysm of our patient was proximal to the
vertebral orifice. In view of the clinical presentations, the
milieu of active infection, the image of a large expanding
pseudoaneurysm with surrounding hematoma and compres-
sion on the neighboring lung that had relatively clear paren-
chyma, and the uneventful recovery course after antibiotics
treatment, it was strongly proposed that the aneurysm in our
patient was primary and mycotic despite our having no direct
microscopic or blood culture evidence. The source of infection
in our case also remained elusive.
Mycotic aneurysm was first described by William Osler in
1885. It often involves the bifurcation or the narrowing portion
of the arterial wall. Clinically, mycotic aortic aneurysm is
relatively rare, with an incidence of about 0.65e2% of all
aortic aneurysms. Staphylococcus aureus, Salmonella, and
Streptococcus species are the most common microorganisms.
Salmonella species frequently involve gastrointestinal tract,
but often there is no history of gastroenteritis. The most
common presentation is fever or abdominal pain. Salmonellavascular stent grafting showed adequate stent positioning, full stent expansion,
neurysm. (B) The contrast medium MDCT image done 3 months after endo-
the mycotic aneurysm and the surrounding hematoma. The vessel lumen was
ography.
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a positive culture growth. Because it carries a high rupture and
mortality rate, we should always keep this possibility in mind,
especially in immunocompromised patients. Although the
sputum culture of our patient grew Salmonella group B,
a frequent microorganism for mycotic aneurysm, his blood
culture was negative. This might be due to partial antibiotic
treatment for alleged pneumonia at the local hospital prior to
current admission. Although pneumonia may be the source of
infection, it was more probable that the patient’s pneumonia
was secondary to the mass effect of the large pseudoaneurysm
and the surrounding hematoma. In the patient, the bacterial
source should be in the gastrointestinal tract as Salmonella
enteritis was firmly diagnosed 11 months later in his second
admission, presenting with typical symptoms and signs.
Mycotic aneurysms involving peripheral arteries are much less
frequent than those involving the aorta. The most frequent
ones are those involving femoral arteries, occurring mostly in
intravenous drug abusers. Blood culture can be negative in up
to 25e50% of cases. Mycotic subclavian artery pseudoa-
neurysms are rare,6e9 usually seen in drug addicts. Risk
factors for mycotic aneurysms include chronic alcoholism,
diabetes mellitus, and chronic renal failure. Our patient did not
have any of these risk factors, and the cause was vague.
Regarding the treatment of mycotic subclavian artery
pseudoaneurysms, there remain controversies.7,8 Some authors
are strongly opposed to the use of stent grafts in infected
aneurysms,7 citing that the infected stents could be a source
for mycotic pseudoaneurysm.18 However, the standard
surgical management, especially the intrathoracic one, might
not be a choice in high-risk patients with unfavorable lesion
locations, like the one presented in this report. On the other
hand, endovascular aneurysm repair may be a less invasive,
but effective, alternative in particular clinical settings, but this
was rarely reported priorly.8 This is because, at one extreme,
endovascular treatment could be associated with smoldering
infection in the prosthetic graft and aneurysmal bed. Stent
thrombosis, oversizing, undersizing, migration, rupture, and
endoleak could be other complications. Therefore, a prolonged
and complete antibiotic treatment is an important adjunct to
endovascular treatment. There is no consensus on how long
the antibiotics should be used after endovascular management.
However, prolonged antibiotic treatment for at least 6 weeks
or even lifetime is suggested in the literature. Third-generation
cephalosporins, especially ceftriaxone and newer quinolones,
were used for Salmonella infection.
Complications after endovascular treatment of mycotic
aneurysms have been reported, including sepsis, aneurysm
rupture with mortality,19 type 1 endoleak with sepsis,20 and
aortoenteric fistula.21 One author even reported Salmonella
infection flare-up years after treatment.21 In our case, intrave-
nous cefotaxime was used for 1 month, and ciprofloxacin for
another 5 months and then stopped based on clinical judgment.
Unfortunately, the use of antibioticswas proved insufficient, and
the infection relapsed 11 months post intervention and turned
out to be lethal in the old patient. However, even at this time,
there was no sign of local infection recurrence at the subclavianstent graft site. One study reported that although early mortality
rate of endovascular repairwas relatively lower than that of open
surgery, rate of late complications such as late aneurysm-related
events could be higher than that of open surgery. Kan et al found
a 12-month survival rate of 39% for patients with persistent
infection but 94% for those whose aneurysms were healed.
Although stent grafting might be a reasonable alternative to
open surgical repair in certain lesions in high-risk patients,
several issues deserve particular attention beforehand. It should
not be considered when active infection has not been controlled
by effective antibiotics. It is not suitable for lesions with vital
branches that could not be sacrificed, lesions without proper
landing zones, or lesions involving long segment with frail
walls. Meticulous treatment planning based on thorough
considerations of clinical and imaging information was key to
successful endovascular stent graft treatment in our case. The
lesion location and vessel characteristics were quite suitable for
endovascular obliteration, and the size and length of the stent
were predecided by radiographic images. The endovascular
repair was approached by bilateral access technique inwhich the
bulky stent graft was introduced retrogradely via left brachial
cutdown to ensure successful device delivery, smooth device
manipulation, and precise stent positioning, whereas the large
guide in the aorta provided antegrade lightening and help
prevent proximal stent dislodgement in case of stent migration
during deployment. The entire procedure was performed
successfully as planned, and there were no neurological
sequelae due to distal embolism or sacrifice of the vertebral
artery. Neither there was any endoleak. Complete resolution of
the aneurysm in follow-up and no recurrence of local infection at
the subclavian site might convey the message that active
infection was eliminated and the risk of aneurysm rupture is
minimal. To the best of our knowledge, only one case of
subclavian mycotic aneurysm treated with stent grafting has
been reported so far. The patient was an immunosuppressed
young girl with Aspergillosis infection, who died of leukemia
relapse 11 months after the procedure.
In conclusion, endovascular stent graft repair of large
subclavian arterymycotic aneurysmmight be a safe and feasible
option for certain high-surgical-risk patients and for surgically
inaccessible lesions, whereas surgical debridement remains the
standard treatment. Endovascular treatment should be tailored
to each individual patient and his/her unique clinical settings
after comprehensive treatment planning. Prolonged anti-
microbiological treatment should be the adjunctive therapy, and
the duration may vary from case to case to reduce the risk of
persistent infection and even sepsis. Treatment of underlying
infection determines the clinical outcome.References
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